Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma-MedSci.cn

Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma

Labbate, C; Woldu, S; Murray, K; Rose, K; Sexton, W; Tachibana, I; Kaimakliotis, H; Jacob, J; Dickstein, R; Linehan, J; Nieder, A; Bjurlin, M; Humphreys, M; Ghodoussipor, S; Quek, M; O'Donnell, M; Eisner, B; Feldman, A; Lotan, Y; Matin, SF

Matin, SF (通讯作者)，Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.

Abstract

Purpose: We describe a novel application of the reverse thermal polymer gel of mitomycin C (UGN-101) as adjuvant therapy after complete endoscopic abl......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma

科室

工具

服务